Kesavan, Jaideep
Watters, Orla
de Diego-Garcia, Laura
Méndez, Aida Menéndez
Alves, Mariana
Dinkel, Klaus
Hamacher, Michael
Prehn, Jochen H. M.
Henshall, David C.
Engel, Tobias
Funding for this research was provided by:
Royal College of Surgeons in Ireland
Article History
Received: 25 March 2023
Accepted: 4 July 2023
First Online: 15 July 2023
Declarations
:
: The human iPSC line was obtained from Culture Collections, Public Health England, UK. Consent was obtained from the donor, by the Sanger institute that reprogrammed the fibroblasts into iPSCs and the line was distributed and used under the terms of an MTA from culture collections and RCSI.
: Not applicable.
: The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. K.D. and M.H. are stakeholders in Lead Discovery Center GmbH and Affectis Pharmaceuticals respectively but had no influence in the study design.